Antimicrobial Resistance (AMR) Control Programs

This contract seeks to implement comprehensive antimicrobial resistance (AMR) control initiatives across healthcare facilities and communities in India, focusing on surveillance systems to monitor resistance patterns and stewardship programs to promote appropriate antibiotic use. The effort aims to establish sustainable infrastructure within medical institutions to track, report, and respond to AMR trends, while integrating evidence-based practices to reduce misuse and overuse of antimicrobials. Additionally, the project includes developing and deploying public awareness campaigns to educate healthcare providers and the general population about the dangers of AMR and the importance of responsible antimicrobial use. The initiative is structured as a subcontract under the U.S. Department of Health and Human Services, specifically through the Centers for Disease Control-GHC, with a NAICS code of 621999 indicating non-specified healthcare services. The contract is open for submission until October 2, 2026, and all activities are expected to be carried out within India, targeting systemic improvements in infection prevention, clinical protocols, and community engagement. The program emphasizes long-term outcomes, requiring robust monitoring, data collection, and reporting mechanisms to ensure accountability and impact, with the ultimate goal of reducing the burden of antimicrobial-resistant infections in the region.